5-Amino-1MQ

5-Amino-1MQ is a small-molecule metabolic compound taken as an oral capsule. It works by inhibiting an enzyme called NNMT (nicotinamide N-methyltransferase) in fat cells. When NNMT is blocked, cellular NAD+ levels rise, which shifts how fat cells manage energy - favoring burning over storing. The tagline is accurate to the mechanism: it is trying to flip fat cells toward a more metabolically active state. This is a different approach to fat loss than GLP-1 agonists, which work through appetite suppression. 5-Amino-1MQ targets the fat cell itself at a metabolic level. It also has minor supporting roles in muscle support and energy, though fat loss is its primary application. It is a good match for people whose main goals include fat loss - often used in conjunction with a GLP-1 agonist or other metabolic support rather than as a standalone. It stacks well with semaglutide, MOTS-c, and NAD+. The oral format is a practical advantage for people who want a needle-free complement to injectable protocols. It is taken as a daily morning capsule. Dose range is 50 to 150 mg per day. Cycle length is 8 to 12 weeks. Evidence is at the emerging stage - early human data exists and it is generally well tolerated, but long-term human trials are not yet completed. It is a research compound and not FDA-approved. No specific contraindications or exclude flags are listed for it - it is not restricted by pregnancy or cancer history in the current data set. Exact dosing and whether it fits your protocol are set with a licensed provider in the PepDepo network at your consult.